Affiliation:
1. Department of Cardiology Amiens University Hospital Amiens France
2. EA 7517 MP3CV Jules Verne University of Picardie Amiens France
3. Groupement des Hôpitaux de l'Institut Catholique de Lille/Faculté libre de Médecine Université Lille Nord de France Lille France
Abstract
Background
Normal‐flow, low‐gradient severe aortic stenosis (
NF
‐
LG
‐
SAS
), defined by aortic valve area <1 cm
2
, mean gradient <40 mm Hg, and indexed stroke volume >35 mL/m
2
, is the most prevalent form of low‐gradient aortic stenosis (
AS
). However, the true severity of
AS
and the management of
NF
‐
LG
‐
SAS
are controversial. The aim of this study was to evaluate the outcome of patients with
NF
‐
LG
‐
SAS
compared with moderate
AS
(
MAS
) and with high‐gradient severe‐AS (HG‐SAS).
Methods and Results
A total of 154 patients with
NF
‐
LG
‐
SAS
, 366 with
MAS
(aortic valve area between 1.0 and 1.3 cm
2
), and 1055 with HG‐SAS were included. On multivariate analysis, after adjustment for covariates of prognostic importance,
NF
‐
LG
‐
SAS
patients did not exhibit an excess risk of mortality compared with
MAS
patients under medical management (hazard ratio=1.13 [95% CI, 0.82‐1.56];
P
=0.45) and under medical and surgical management (hazard ratio 1.06 [95% CI, 0.79‐1.43];
P
=0.70), even after further adjustment for aortic valve replacement (hazard ratio=1.09 [95% CI, 0.81‐1.48];
P
=0.56). The 6‐year cumulative incidence of aortic valve replacement (performed in accordance with guidelines) was comparable between the 2 groups (39±4% for
NF
‐
LG
‐
SAS
and 35±3% for
MAS
,
P
=0.10). After propensity score matching (n=226),
NF
‐
LG
‐
SAS
and
MAS
patients also had comparable outcomes under medical (
P
=0.41) and under medical and surgical management (
P
=0.52).
NF
‐
LG
‐
SAS
had better outcomes than HG‐SAS patients (adjusted hazard ratio 1.84 [95% CI, 1.18‐2.88];
P
<0.001).
Conclusions
This study shows that patients with
NF
‐
LG
‐
SAS
have a comparable outcome to those with
MAS
when aortic valve replacement is performed during follow‐up according to guidelines, mostly at the stage of HG‐SAS. Rigorous echocardiographic assessment to rule out measurement errors and close follow‐up are essential to detect progression to true severe AS
in NF
‐
LG
‐
SAS
.
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Cardiology and Cardiovascular Medicine
Cited by
33 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献